Market Research Logo

Global Blood Plasma Market: Industry Analysis & Outlook (2017-2021)

Global Blood Plasma Market: Industry Analysis & Outlook (2017-2021)

Plasma is obtained from blood after separation from red blood cells, white blood cells and platelets. The major components of blood plasma include proteins, amino acids, and other essential nutrients. Among these, proteins form the most important part of plasma and constitutes albumin, immunoglobulin, factor VIII, factor IX, alpha1 and many more. Plasma proteins are extracted from blood and used for many therapeutic indications.

Blood plasma is important because they fight off foreign substances that invade the body and transport nutrients and water. Plasma and recovered plasma are used to produce therapies that treat people with rare, chronic diseases and disorders such as primary immunodeficiency, hemophilia and genetic lung disease, as well as in the treatment of trauma, burns and shock. North America is the largest market for blood plasma as it has the most advanced infrastructure which has helped in increasing plasma collections over the time.

Growth factors of the global blood plasma market include increased diagnosis rate, rise in plasma collections and robust growth in emerging economies. Major trends of the market include increase in fractionation capacity, growing AATD market potential, and innovation in therapeutics. The market growth is hindered by factors such as high cost of treatment, lengthy approval process and high R&D costs.

The report offers an in-depth analysis of the global blood plasma market. It also covers global as well as regional aspect of the market. The report profiles the top notch players of the market including Shire Plc., CSL Limited, Grifols, S.A., and Octapharma Inc."


1. Market Overview
1.1 Blood Plasma
Table 1: Components of Blood Plasma
1.2 Blood Plasma Derivatives
Table 2: Blood Plasma Protein Breakup
1.3 Functions of Blood Plasma
Table 3: Functions of Blood Plasma
1.4 Plasma Collection
2. Global Market Analysis
2.1 Global Blood Plasma Market Forecast by Value
Table 4: Global Blood Plasma Market Forecast by Value (2016-2021)
2.2 Global Blood Plasma Fractionation Capacity Forecast
Table 5: Global Blood Plasma Fractionation Capacity Forecast (2016-2021)
2.3 Global Blood Plasma Market by Region
Table 6: Global Blood Plasma Market by Region (2016)
2.4 Global Blood Plasma Market by Segment
Table 7: Global Blood Plasma Market by Segment (2016)
2.5 Global Immunoglobulin Market
2.5.1 Global Immunoglobulin Market Forecast by Value
Table 8: Global Immunoglobulin Market Forecast by Value (2016-2021)
2.5.2 Global Immunoglobulin Market Forecast by Volume
Table 9: Global Immunoglobulin Market Forecast by Volume (2016-2021)
2.5.3 Global Immunoglobulin Market Volume by Region
Table 10: Global Immunoglobulin Market Volume by Region (2016)
2.5.4 Global Immunoglobulin Market by Types
Table 11: Global Immunoglobulin Market by Types (2016)
2.5.5 Global Immunoglobulin Population by Indication
Table 12: Global Immunoglobulin Population by Indication (2016)
2.6 Global Albumin Market
2.6.1 Global Albumin Market Forecast by Value
Table 13: Global Albumin Market Forecast by Value (2016-2021)
2.6.2 Global Albumin Market Forecast by Volume
Table 14: Global Albumin Market Forecast by Volume (2016-2021)
2.6.3 Global Albumin Market Volume by Region
Table 15: Global Albumin Market Volume by Region (2016)
2.7 Global Factor VIII Market
2.7.1 Global Factor VIII Market Forecast by Value
Table 16: Global Factor VIII Market Forecast by Value (2016-2021)
2.7.2 Global Factor VIII Market Forecast by Volume
Table 17: Global Factor VIII Market Forecast by Volume (2016-2021)
2.7.3 Global Factor VIII Market by Type
Table 18: Global Factor VIII Market by Type (2016)
3. Regional Analysis
3.1 The US
3.1.1 The US Blood Plasma Market by Segments
Table 19: The US Blood Plasma Market by Segment (2016)
3.1.2 The US Immunoglobulin Market Forecast by Value
Table 20: The US Immunoglobulin Market Forecast by Value (2016-2021)
3.1.3 The US Immunoglobulin Market Forecast by Volume
Table 21: The US Immunoglobulin Market Forecast by Volume (2016-2021)
3.1.4 The US Immunoglobulin Market Volume by Segment
Table 22: The US Immunoglobulin Market Volume by Segment (2016)
3.1.5 The US Immunoglobulin Market by Specialty
Table 23: The US Immunoglobulin Market by Specialty (2016)
3.1.6 The US Albumin Market Forecast by Volume
Table 24: The US Albumin Market Forecast by Volume (2016-2021)
3.2 China
3.2.1 China’s Blood Plasma Market Forecast by Value
Table 25: China’s Blood Plasma Market Forecast by Value (2016-2021)
3.2.2 China’s Blood Plasma Market by Segments
Table 26: China’s Blood Plasma Market by Segments (2016)
3.2.3 China’s Albumin Market Forecast by Value
Table 27: China’s Albumin Market Forecast by Value (2016-2021)
3.2.4 China’s Immunoglobulin Market Forecast by Value
Table 28: China’s Immunoglobulin Market Forecast by Value (2016-2021)
3.2.5 China’s Factor VIII Market Forecast by Value
Table 29: China’s Factor VIII Market Forecast by Value (2016-2021)
4. Market Dynamics
4.1 Trends & Developments
4.1.1 Increasing Fractionation Capacity
Table 30: Fractionation Capacity of Key Market Players (2013-2022E)
4.1.2 Growing AATD Market Potential
Table 31: Global Alpha1 Patient Population (2016)
4.1.3 Innovation in Therapeutics Via Existing and New Proteins
Table 32: Therapeutic Products Under Development (2016)
4.2 Growth Drivers
4.2.1 Increased Diagnosis of Disease Treated by Immunoglobulin
Table 33: The US CIDP Market Opportunity (2016)
4.2.2 Increasing Plasma Collection
Table 34: Plasma Collection in the US (2012-2016)
4.2.3 Growing Blood Plasma Market in Emerging Economies
4.2.4 Popularity of Albumin in Asian Countries
Table 35: Albumin Consumption Per Capita by Country (2016)
4.2.5 Increasing Healthcare Expenditure
Table 36: Global Healthcare Expenditure (2012-2016)
4.2.6 Escalating Ageing Population
Table 37: Global Ageing Population of 60 Years or Older (2000-2030E)
4.3 Challenges & Issues
4.3.1 High Cost of Treatment
4.3.2 Unclear & Lengthy Process to Open Plasma Centre
4.3.3 High R&D Costs
5. Competitive Landscape
5.1 Global Market
5.1.1 Global Blood Plasma Market Share
Table 38: Global Blood Plasma Market Share by Company (2016)
5.1.2 Global Immunoglobulin Market Share
Table 39: Global Immunoglobulin Market Share by Company (2016)
5.1.3 Global Albumin Market Share
Table 40: Global Albumin Market Share by Company (2016)
5.1.4 Global Plasma-Derived Factor VIII Market Share
Table 41: Global Plasma-Derived Factor VIII Market Share by Company (2016)
5.1.5 Global Alpha1 Market Share
Table 42: Global Alpha1 Market Share by Company (2016)
5.1.6 Global Blood Plasma Centers by Major Players
Table 43: Global Blood Plasma Centers by Major Players (2016)
6. Company Profiles
6.1 Shire Plc.
6.1.1 Business Overview
Table 44: Shire Plc. Revenue Share by Franchise (2016)
6.1.2 Financial Overview
Table 45: Shire PLC’s Revenue and Net Income (2012-2016)
6.1.3 Business Strategies
Table 46: Shire PLC’s Major Product Approvals & Launches (2016)
Table 47: Shire PLC’s Major Product Pipeline (2016)
6.2 CSL Limited
6.2.1 Business Overview
Table 48: CSL Limited’s Revenue Share by Products (2016)
6.2.2 Financial Overview
Table 49: CSL Limited’s Revenue and Net Profit (2012-2016)
6.2.3 Business Strategies
Table 50: Research & Development Investments of CSL Limited (2012-2016)
Table 51: CSL Ltd.’s Major Product Development (2016)
6.3 Grifols, S.A.
6.3.1 Business Overview
Table 52: Grifols, S.A. Revenue Share by Business Segments (2016)
6.3.2 Financial Overview
Table 53: Grifols, S.A. Revenue and Gross Profit (2012-2016)
6.3.3 Business Strategies
6.4 Octapharma, Inc.
6.4.1 Business Overview
6.4.2 Financial Overview
Table 54: Octapharma, Inc. Revenue (2012-2016)
6.4.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report